Table 5– Number of asthma-related serious adverse events (SAEs) by daily dose of formoterol in the primary dataset

Daily dose of formoterol	Patients	Patients reporting at least one asthma-related SAE
9 μg^#	6348	88 (1.39)
18 μg	16 643	95 (0.57)
36 μg	909	4 (0.44)
As-needed use, adjustable dosing or uncertain dose	43 480	276 (0.63)
Total	67 380	463 (0.79)

Data are presented as n or n (%). ^#: includes the 114 children who received 80/4.5 μg budesonide/formoterol + terbutaline as needed in trial SD-039-0673.